Amendment One: Azure 600 Imaging System
Closed Solicitation Posted
- Solicitation number
- 75F40124Q00416
- Agency
- FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Silver Spring, Maryland 20993, United States
- Points of contact
-
- Patricia Natividad patricia.natividad@fda.hhs.gov (301) 796-8919
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration (FDA) is seeking to procure an Azure 600 Imaging System through a sole source acquisition from Azure Biosystems. The imaging system, which provides high sensitivity and specificity in detecting and quantifying proteins, is an integral tool for the FDA's efforts in quality control, drug development, medical device evaluation, and safety assessments. The solicitation is being issued as a Request for Quote (RFQ) with a NAICS code of 334516 and a small business size standard of 1000 employees. Quotes are due by August 14, 2024, and the government reserves the right to award without discussions if the initial offer provides the best value.
This acquisition is set aside for small businesses and will be awarded as a firm-fixed price contract. The solicitation amendment adds a trade-in requirement for the existing Azure C600 system. The place of performance is Silver Spring, MD, and the FDA requires delivery of the new Azure 600 Imaging System within 60 days of award to their laboratory.
Notice text
2 versions
Update #2 · Latest ·
Amendment One:
The reason for Amendment One is to add the trade in for the existing Azure C600 (Serial Number 60446). All language changes is in Red lettering.
Updated QUOTES DUE: All quotes are due electronically to via email to Patricia.Natividad@fda.hhs.gov no later than August 14, 2024, 10:00 a.m. Eastern Standard Time.
All other Terms and Conditions remain the same.
***************************************************************************************
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024.
THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED.and Notice of intent to Sole Source.
The solicitation number for this acquisition is 75F40124Q00416 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 334516 and the Small Business Size Standard is 1000 employees. This will be awarded as Firm-Fixed Price and completed as a Sole Source to Azure Biosystems. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary.
The U.S. Food and Drug Administration (FDA) requires a Azure 600 Imaging System.
BACKGROUND AND OVERVIEW
Imager systems with chemiluminescence for Western blotting are integral tools in the FDA's efforts to protect public health. These systems provide high sensitivity and specificity in detecting and quantifying proteins, essential for quality control, drug development, medical device evaluation, and safety assessments. By leveraging advanced imaging technology, the FDA ensures that biological products and medical devices are safe, effective, and reliable
See Attachment for the Solicitation CDER-2024-122015 07292024, and Solicitation Amendment One CDER-2024-122015
Update #1 ·
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024.
THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED.and Notice of intent to Sole Source.
The solicitation number for this acquisition is 75F40124Q00416 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 334516 and the Small Business Size Standard is 1000 employees. This will be awarded as Firm-Fixed Price and completed as a Sole Source to Azure Biosystems. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary.
The U.S. Food and Drug Administration (FDA) requires a Azure 600 Imaging System.
BACKGROUND AND OVERVIEW
Imager systems with chemiluminescence for Western blotting are integral tools in the FDA's efforts to protect public health. These systems provide high sensitivity and specificity in detecting and quantifying proteins, essential for quality control, drug development, medical device evaluation, and safety assessments. By leveraging advanced imaging technology, the FDA ensures that biological products and medical devices are safe, effective, and reliable
See Attachment for the Solicitation CDER-2024-122015 07292024
Attachments
| File | Type | Posted |
|---|---|---|
| Solicitation Amendment One CDER-2024-122015 07292024.pdf | ||
| Solicitation CDER-2024-122015 07292024.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Amendment One: Azure 600 Imaging System | Solicitation | |
| Azure Imager System 1 Each (Ea) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity